Medical Oncology

We administer a wide range of chemotherapy regimens tailored to the specific type and stage of cancer.

• Conventional chemotherapy targets rapidly dividing cancer cells and is delivered in treatment cycles.
• Metronomic chemotherapy uses lower, more frequent dosing to minimise side effects and inhibit tumour blood vessel growth.

Our day-care unit allows most patients to return home the same day, ensuring comfort and convenience.

Immunotherapy helps the body’s own immune system recognise and destroy cancer cells.

• Checkpoint inhibitors (such as PD-1/PD-L1 and CTLA-4 blockers) re-activate immune cells to fight cancer.
• Monoclonal antibodies specifically target proteins on cancer cells for more precise treatment.

These therapies have revolutionised care in cancers like lung, kidney, melanoma, head & neck and several others.

Targeted therapies work by blocking specific genes and pathways that drive cancer growth.

• TKIs (Tyrosine Kinase Inhibitors)
• mTOR inhibitors
• Other molecularly targeted drugs

These treatments are often oral, well-tolerated and highly effective in cases with identifiable genetic mutations (EGFR, ALK, HER2, BRAF, etc.). Regular monitoring ensures optimal dosing and safety.

Hormonal treatments are essential for hormone-dependent cancers such as breast and prostate cancer.
They function by blocking hormone production or preventing hormones from stimulating cancer growth.
These can be taken orally or through injections and are commonly used across early, advanced and metastatic stages.

Certain cancers require intensified chemotherapy regimens for better outcomes.
High-dose protocols are delivered with strict monitoring, supportive medications and access to critical care if needed.
These protocols aim to maximise tumour kill while safeguarding the patient through advanced supportive strategies.

Biological agents, including newer monoclonal antibodies, fusion proteins and anti-angiogenic drugs, directly influence tumour biology and the tumour microenvironment.
These therapies may be used alone or in combination with chemotherapy to enhance effectiveness and prolong survival.

Supportive care forms the backbone of safe cancer treatment.
Our unit provides:

• Antiemetics to prevent nausea and vomiting
• Growth factors (G-CSF / GM-CSF) to support white cell recovery
• Blood and platelet transfusions
• Electrolyte and fluid management
• Pain and symptom management

This ensures treatments continue smoothly with minimal interruptions or complications.

Every cancer behaves differently, and our approach reflects this individuality.
Treatment decisions are guided by:

• Molecular profiling
• Genetic mutations
• Receptor status
• Immunohistochemistry (IHC) results
• PET/CT and functional imaging

This precision-driven strategy allows us to choose the therapy with the highest likelihood of success and the lowest risk of toxicity.